Each study has a usefulness score out of 100 (rubric version 4.0). Tap a score to see what makes it up.
Highest usefulness score first. Studies without a score come last.
-
White Matter Disease is increasingly being recognized as an important cause of cognitive decline and dementia.
-
An important concept in neurobiology is "neurons that fire together, wire together" which means that the formation and maintenance of synapses is promoted by activation of those synapses.
-
Reactive species play an important role in physiological functions.
-
Glucagon-like peptide-1 (GLP-1) is released in response to meals and exerts important roles in the maintenance of normal glucose homeostasis.
-
Ginkgo leaf is the most used form of supplement for cognitive ailments.
-
Biochemical integrity of the brain is vital for normal functioning of the central nervous system (CNS).
-
Glucagon-like peptide-1 (GLP-1) is an incretin hormone shown to be active in the treatment of type-2 diabetes (T2D) and has also been shown as efficacious in Alzheimer's disease (AD).
-
The oral microbiome is established within a few minutes after birth and consists of stable multi-species communities that engage in a dynamic equilibrium with the host immune system.
-
Dementia, closely linked to environmental predisposing factors such as diet, is a public health problem of increasing magnitude: currently there are more than 35 million patients with Alzheimer´s disease, and is expected to exceed 135 million by 2050.
-
Alzheimer disease (AD) is a progressive neurodegenerative disease that affects the elderly population with complex etiology.
-
The research on aging and age-related diseases, especially the neurodegenerative diseases, is on the fast track.
-
The evidence of strong pathological associations between type 2 diabetes and Alzheimer's disease (AD) has increased in recent years.
-
Alzheimer's disease (AD) is currently the most common incurable forms of dementia.
-
Type 2 diabetes (T2D) is a high risk factor for Alzheimer's disease (AD).
-
Increasing evidence has shown that type 2 diabetes (T2D) is a risk factor for Alzheimer's disease.
-
38/100
Benefits of dietary moderation when on a Mediterranean diet type (MD) have been known for well over half a century.
-
Vaccines are commonly used as a preventive medicine for infectious diseases worldwide; however, the trial for an amyloid beta vaccine against Alzheimer's disease will open a new concept in vaccination.
-
38/100
Considerable attention has focused on the prevention of dementia in terms of non-genetic risk factors, including midlife obesity, especially visceral obesity associated with hyperglycemia, hypertension, and hypercholesterolemia.
-
38/100
Glucagon-like peptide-1 (GLP-1) is derived from the processing of proglucagon in intestinal L-cells and releases insulin from pancreatic β-cells as an incretin.
-
Synapse loss and synaptic dysfunction are pathological processes already involved in the early stages of Alzheimer's disease (AD).
-
The prevalence of the cardiorenal metabolic syndrome (CRS) is increasing in parallel with obesity, type 2 diabetes mellitus, Alzheimer's disease, and other forms of dementia.
-
38/100
The combination of memantine, an N-methyl-d-aspartate (NMDA) receptor antagonist, with an acetylcholinesterase inhibitor (AChEI) is the current standard of care in Alzheimer's disease (AD).
-
Redox degenerative reactions of the biological system inevitably produce reactive oxygen species (ROS) and their derivatives.
-
There is a cluster of risk factors for Type 2 diabetes and vascular disease that include high blood glucose, obesity, high blood pressure, increased blood triacylglycerols and insulin resistance.
-
There is some evidence from recent observational studies that hyperhomocysteinemia is a risk factor for cognitive dysfunction, including Alzheimer's disease and vascular dementia.
From across this topic
10 of the 1,048 studies in this topic, picked by a fixed rule (a hash of each study's address), not by score or date; each page of this list shows a different 10. The same 10 appear here every time.
- Ketogenic diet and BHB rescue the fall of long-term potentiation in an Alzheimer's mouse model and stimulates synaptic plasticity pathway enzymes
- Neurodegenerative diseases: From available treatments to prospective herbal therapy
- Changes of Colonic Bacterial Composition in Parkinson's Disease and Other Neurodegenerative Diseases
- Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease
- Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity
- Type 1 diabetes is associated with higher plasma levels of biomarkers of neurodegeneration and neuroinflammation
- Metabolic Syndrome, Cognitive Impairment and the Role of Diet: A Narrative Review
- Dulaglutide ameliorates STZ induced AD-like impairment of learning and memory ability by modulating hyperphosphorylation of tau and NFs through GSK3β
- The microbiome and disease: reviewing the links between the oral microbiome, aging, and Alzheimer's disease
- Early-Stage Alzheimer’s Disease Is Associated with Simultaneous Systemic and Central Nervous System Dysregulation of Insulin-Linked Metabolic Pathways